INJECTION SITE JOINT ERYTHEMA

INJECTION SITE JOINT ERYTHEMA was reported 25 times

INJECTION SITE JOINT ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 APOMORPHINE HYDROCHLORIDE 1 0.0006
1 TRALOKINUMAB-LDRM 1 0.0001
2 INCLISIRAN 1 0.0001
3 ASFOTASE ALFA 1 0.0001
4 PEGINTERFERON BETA-1A 1 0.0001
5 PRAMIPEXOLE 1 0.0001
6 ARMODAFINIL 1 0.0000
7 CIPROFLOXACIN TABLETS 3 0.0000
8 GLATIRAMER ACETATE 2 0.0000
9 GALCANEZUMAB-GNLM 1 0.0000
10 MODAFINIL 1 0.0000
11 CIPROFLOXACIN HYDROCHLORIDE 3 0.0000
12 CYANOCOBALAMIN 1 0.0000
13 GUSELKUMAB 1 0.0000
14 GLIMEPIRIDE 1 0.0000
15 TERIPARATIDE 2 0.0000
16 DALFAMPRIDINE 1 0.0000
17 DIAZEPAM ORAL 1 0.0000
18 INFLIXIMAB 2 0.0000
19 DIAZEPAM 1 0.0000
20 BISOPROLOL FUMARATE 1 0.0000
21 ESCITALOPRAM 1 0.0000
22 SECUKINUMAB 1 0.0000
23 SIMVASTATIN 1 0.0000
24 PANTOPRAZOLE 1 0.0000
25 DUPILUMAB 2 0.0000
26 ASPIRIN 2 0.0000
27 ADALIMUMAB 2 0.0000
28 GABAPENTIN 1 0.0000
29 FUROSEMIDE 1 0.0000
30 OMEPRAZOLE MAGNESIUM 1 0.0000